
Sanofi and Novavax Forge Co-Exclusive Licensing Deal to Co-Market COVID-19 Vaccine and Innovate Flu-COVID-19 Combination Vaccines
Sanofi, in its pursuit of a robust vaccine portfolio, has forged a co-exclusive licensing agreement with Novavax, a biotech firm headquartered in Maryland, USA. The terms of this agreement encompass several key elements: Sanofi gains a co-exclusive license to globally…












